Stay updated on AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.

Latest updates to the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. This appears to be a maintenance update with no changes to trial data or eligibility.SummaryDifference0.1%

- Check25 days agoChange DetectedRemoved the government funding lapse notice banner from the page footer; the trial details, eligibility criteria, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check47 days agoChange DetectedNo significant changes detected in core study details, eligibility criteria, or locations; minor UI tweaks observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check69 days agoChange DetectedThe page updates to v3.2.0 and adds a government-operating-status notice, replacing the previous v3.1.0 reference with current status information and links for operating status.SummaryDifference4%

- Check76 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.SummaryDifference0.1%

- Check90 days agoChange Detected- Updated revision from v3.0.1 to v3.0.2. - Removed the 'Back to Top' element.SummaryDifference0.3%

Stay in the know with updates to AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.